Vanguard Therapeutics Private Limited - Company Profile

It is a pharma private limited company based in Andhra Pradesh, Telangana, India, established in 1986.
1986 Andhra Pradesh, Telangana, India Active
Last Updated:
Access Report
About Vanguard Therapeutics Private Limited

Vanguard Therapeutics Private Limited, a active private limited company, was established on 07 April 1986 in Andhra Pradesh, Telangana, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U70102TG1986PTC006360. Registered under ROC Roc Hyderabad. it is unlisted. It has an authorized capital of ₹15.00 Cr and a paid-up capital of ₹7.66 Cr.

It upholds a compliant status. Employing 2 professional, Its leadership includes Potineni Swetha (Director), Potineni Koteswara Rao (Managing Director), Potineni Vindhya Rani (Director). Past directors included Muppa Ashok Vardhan, Potineni Swetha, Subba Rao Ambati. It holds ₹8.16 M open charges and ₹14.65 Cr settled loans. Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at 17,3Rt,3Rd Floor,Opp.Andhrabank Lane,S.R.Nagar, Hyderabad, Andhra Pradesh, Telangana, 500038.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U70102TG1986PTC006360

  • Registration Number

    006360

  • Incorporation Date

    07 April 1986

  • Authorized Capital

    ₹15.00 Cr

  • Paid-Up Capital

    ₹7.66 Cr

  • ROC Code

    Roc Hyderabad

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 15.00 Cr
  • Paid Up Capital ₹ 7.66 Cr
  • Company Age 40 Year, 2 Months
  • Last Filing with ROC 31 Mar 2025
  • Open Charges ₹ 8.16 M
  • Satisfied Charges ₹ 14.65 Cr
  • Revenue Growth **** 15.95%
  • Profit Growth **** 70.27%
  • Ebitda **** 60.67%
  • Net Worth 13.45%
  • Total Assets **** 23.25%
Company report

Vanguard Therapeutics Private Limited

Company Report FY 2026-2027

Comprehensive Company Insights

Explore comprehensive insights into Vanguard Therapeutics Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Vanguard Therapeutics Private Limited?
Current Directors
Name Designation Appointment Date Status
Potineni Swetha Director 01 Aug 2022 Current
Potineni Koteswara Rao Managing Director 07 Apr 1986 Current
Potineni Vindhya Rani Director 05 Feb 1991 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Director 06 Apr 2009 Past
Pramod Abcsdd Director 30 Apr 2012 Past
Pramod Abcsdd Director 25 Oct 2007 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Vanguard Therapeutics.

Vanguard Therapeutics Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 15.95% increase. The company also saw a substantial improvement in profitability, with a 70.27% increase in profit. The company's net worth Soared by an impressive increase of 13.45%.

Vanguard Therapeutics revenue growth over time
Vanguard Therapeutics profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 15.95%
*******
*******
*******
*******
Revenue from Operations
*******
 15.99%
*******
*******
*******
*******
Total Assets
*******
 23.25%
*******
*******
*******
*******
Profit or Loss
*******
 70.27%
*******
*******
*******
*******
Net Worth
*******
 13.45%
*******
*******
*******
*******
EBITDA
*******
 60.67%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Vanguard Therapeutics?

In 2023, Vanguard Therapeutics had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹8,156,426.00

Satisfied Charges

₹146,455,000.00

Charges Breakdown by Lending Institutions
  • Hdfc Bank Limited : 0.82 Cr
Latest Charge Details
Date Lender Amount Status
11 Dec 2024 Hdfc Bank Limited ₹8.16 M Open
30 Nov 2013 Hdfc Bank Limited ₹4.95 Cr Satisfied
07 Feb 2008 3I Infotech Trusteeship Services Limited ₹5.00 Cr Satisfied
31 Dec 2004 Icici Bank Ltd ₹3.75 Cr Satisfied
02 Mar 2002 The Karnataka Bank Ltd ₹1.50 M Satisfied

Explore comprehensive loan charge details -

How Many Employees Work at Vanguard Therapeutics?

Vanguard Therapeutics has a workforce of 2 employees as of Apr 04, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Vanguard Therapeutics, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Vanguard Therapeutics's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Vanguard Therapeutics
Recent Activity within the Organization
  • Annual General Meeting

    Vanguard Therapeutics Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was recorded as a recent event.

  • Balance Sheet

    Progress on Vanguard Therapeutics Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Hyderabad. was documented.

  • Charges

    The activity A charge with Hdfc Bank Limited amounted to Rs. 0.82 Cr with Charge ID 101034520 was registered on 11 Dec 2024. was completed.

  • Director Appointment

    The activity Potineni Swetha was appointed as a Director was appointed as a Director on 01 Aug 2022 & has been associated with this company since 3 years 11 months . was completed.

  • Charges

    Progress on A charge registered on 30 Nov 2013 via Charge ID 10462933 with Hdfc Bank Limited was fully satisfied on 28 Sep 2021. was documented.

  • Charges

    Progress on A charge with Hdfc Bank Limited of Rs. 4.95 Cr registered on 30 Nov 2013 with Charge ID 10462933 was modified on 23 Dec 2020. was documented.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Vanguard Therapeutics Private Limited?

The CIN of Vanguard Therapeutics Private Limited is U70102TG1986PTC006360.

Where is Vanguard Therapeutics Private Limited headquartered?

Vanguard Therapeutics Private Limited is headquartered at 17,3Rt,3Rd Floor,Opp.Andhrabank Lane,S.R.Nagar, Hyderabad, Andhra Pradesh, Telangana, 500038.

When was Vanguard Therapeutics Private Limited incorporated?

Vanguard Therapeutics Private Limited was incorporated on 07 April 1986.

Who are the current directors of Vanguard Therapeutics Private Limited?

The current directors of Vanguard Therapeutics Private Limited are

What is the primary industry of Vanguard Therapeutics Private Limited?

The primary industry of Vanguard Therapeutics Private Limited is Manufacturing.

Is Vanguard Therapeutics Private Limited a listed company?

Vanguard Therapeutics Private Limited is unlisted.

What is the capital structure of Vanguard Therapeutics Private Limited?

The authorized capital of Vanguard Therapeutics Private Limited is ₹15.00 Cr, and the paid-up capital is ₹7.66 Cr.

What is the compliance status of Vanguard Therapeutics Private Limited?

The compliance status of Vanguard Therapeutics Private Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available